封面
市场调查报告书
商品编码
1945445

2026年全球微流体皮肤贴片市场报告

Lab-On-Skin Microfluidic Patch Global Market Report 2026

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,皮肤贴片式实验室微流体晶片市场呈指数级增长,预计将从2025年的14.4亿美元增长到2026年的17.3亿美元,复合年增长率达20.1%。这一增长可归因于微流体技术的进步、穿戴式医疗技术的广泛应用、运动分析的成长、对非侵入性诊断需求的增加以及生物流体分析研究的开展。

预计未来几年,基于实验室的皮肤微流体贴片市场将快速成长,到2030年市场规模将达到35.7亿美元,复合年增长率(CAGR)为19.9%。预测期内的成长要素包括:与人工智慧驱动的分析技术的整合、个人化医疗的扩展、远端患者监护的成长、健身和健康领域应用的日益广泛,以及贴片材料的技术创新。预测期内的主要趋势包括:持续健康监测、非侵入性诊断、个人化医疗设备、运动和健身分析以及即时生物标记检测。

预计未来几年,人们对个人化医疗日益增长的兴趣将推动皮肤微流体贴片市场的扩张。个人化医疗是一种基于个人基因资讯、生物标记和临床特征客製化医疗方案和预防策略的医疗方法,旨在提高治疗效果。基因组学和生物技术的进步推动了个人化医疗的日益普及,这些进步使得精准诊断和标靶治疗成为可能,从而提高治疗效果并减少不必要的干预。皮肤微流体贴片透过持续监测独特的生物标誌物,实现即时、个人化的治疗决策,进而助力个人化医疗的发展。例如,根据美国非营利组织个人化医疗联盟(PMC)2024年2月发布的消息,美国食品药物管理局(FDA)在2023年核准了16种针对罕见疾病患者的新型个人化疗法,较2022年的6种显着增加。因此,人们对个人化医疗日益增长的兴趣正在推动皮肤微流体贴片市场的成长。

在皮肤贴片实验室微流体贴片市场运营的公司正在开发先进的微流体技术,例如汗液感测贴片,以支援即时健康监测和个人化诊断。汗液感测贴片是一种穿戴式设备,能够收集和分析汗液,从而持续追踪生物标记、电解质和其他生理指标。例如,总部位于美国的数位健康公司Epicore Biosystems Inc.于2024年4月推出了“Connected Hydration”,这是一款可与行动应用程式连接的可穿戴微流体流控贴片。它透过持续监测汗水和电解质,帮助工业工人预防脱水和中暑。它提供即时、个人化的补水资讯、振动警报和基于人工智慧的建议,以在疲劳或受伤发生之前优化液体摄取量。 「Connected Hydration」整合了皮肤贴片实验室感测技术、云端分析和长寿命电池系统,有助于提高全球工业领域在恶劣高温环境下的工人安全、生产力和耐力。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球皮肤微流体贴片市场:吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧(AI)和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
  • 主要趋势
    • 持续健康监测
    • 非侵入性诊断
    • 个人化医疗器材
    • 运动与健身分析
    • 即时生物标记检测

第五章 终端用户产业市场分析

  • 医院和诊所
  • 居家医疗
  • 研究所
  • 运动健身中心
  • 老年人和慢性疾病患者

第六章 市场:宏观经济情景,包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响,以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球皮肤微流体贴片市场:PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素和限制因素)
  • 全球皮肤微流体贴片市场规模、对比及成长率分析
  • 全球皮肤微流体贴片市场表现:规模与成长,2020-2025年
  • 全球皮肤微流体贴片市场预测:规模与成长,2025-2030年,2035年预测

第八章 全球潜在市场规模(TAM)

第九章 市场细分

  • 依产品类型
  • 诊断补丁、监控补丁
  • 依材料类型
  • 聚合物基、混合及其他材料类型
  • 透过使用
  • 医疗保健监测、疾病诊断、运动健身及其他应用
  • 最终用户
  • 医院和诊所、居家医疗、研究机构、体育和健身中心以及其他最终用户
  • 按类型细分:诊断补丁
  • 基于汗液的微流体诊断贴片、组织液微流体诊断贴片、葡萄糖和代谢物检测微流体贴片、电解质和生物标记分析微流体贴片、多成分分析型皮肤实验室诊断贴片
  • 按类型细分:监控补丁
  • 用于连续水合状态监测的微流体贴片、用于连续乳酸水平监测的微流体贴片、用于电解质平衡监测的微流体贴片、用于压力和疲劳监测(基于生物化学)的微流体贴片、用于个性化健康监测的皮肤实验室贴片

第十章 区域与国家分析

  • 全球皮肤微流体贴片市场:区域分析、预测及成长,2020-2025年、2025-2030年预测、2035年预测
  • 全球皮肤微流体贴片市场:依国家划分、绩效及预测(2020-2025年、2025-2030年预测、2035年预测)

第十一章 亚太市场

第十二章:中国市场

第十三章 印度市场

第十四章 日本市场

第十五章:澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章:西欧市场

第21章英国市场

第22章 德国市场

第23章:法国市场

第24章:义大利市场

第25章:西班牙市场

第26章 东欧市场

第27章:俄罗斯市场

第28章 北美市场

第29章:美国市场

第30章:加拿大市场

第31章 南美洲市场

第32章:巴西市场

第33章 中东市场

第34章:非洲市场

第35章 市场监理与投资环境

第36章:竞争格局与公司概况

  • 皮肤微流体贴片市场:竞争格局及市场占有率(2024年)
  • 皮肤微流体贴片市场:公司估值矩阵
  • 皮肤微流体贴片市场:公司概况
    • Epicore Biosystems
    • Xsensio SA
    • Persperity Health Inc.
    • Nutromics Pty Ltd.
    • Biolinq Inc.

第37章:其他领先和创新企业

  • Flow Bio Ltd., GraphWear Technologies Inc., GENTAG Inc., Nemaura Medical Inc., Kenzen Inc., Aline Inc., Eccrine Systems Inc., Nix Biosensors, Sonera, Zansors LLC, PointFit Technology Co. Ltd., Bitome Inc., Arma Biosciences, VivaLNK Inc., MC10 Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章:高潜力市场国家、细分市场与策略

  • 2030年皮肤微流体贴片市场:提供新机会的国家
  • 2030年皮肤微流体贴片市场:充满新机会的细分市场
  • 2030年皮肤微流体贴片市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MLOSM01_G26Q1

A lab-on-skin microfluidic patch is a wearable device that combines microfluidic technology with a flexible, skin-adhering surface to continuously collect and analyze biofluids such as sweat, interstitial fluid, or tears. It operates as a compact laboratory on the skin, allowing real-time monitoring of physiological indicators such as electrolytes, glucose, lactate, and hydration levels for applications in health diagnostics, athletic performance, and personalized medicine.

The primary product types of lab-on-skin microfluidic patches include diagnostic patches, therapeutic patches, monitoring patches, and others. Diagnostic patches are skin-worn devices designed to detect and identify biomarkers such as ions, metabolites, or proteins that reflect disease states or physiological conditions. These patches are composed of materials such as polymer-based, paper-based, hybrid, and others. They are used in healthcare monitoring, disease diagnosis, drug delivery, sports and fitness, and other applications, serving end-users such as hospitals and clinics, homecare, research institutes, sports and fitness centers, and others.

Tariffs on microfluidic components and polymer substrates have affected the lab-on-skin microfluidic patch market, increasing costs of wearable diagnostic and therapeutic patches, especially in North America and Europe. However, this drives regional manufacturing initiatives and encourages innovation in alternative, cost-effective materials, supporting localized supply chains and market resilience.

The lab-on-skin microfluidic patch market research report is one of a series of new reports from The Business Research Company that provides lab-on-skin microfluidic patch market statistics, including lab-on-skin microfluidic patch industry global market size, regional shares, competitors with a lab-on-skin microfluidic patch market share, detailed lab-on-skin microfluidic patch market segments, market trends and opportunities, and any further data you may need to thrive in the lab-on-skin microfluidic patch industry. This lab-on-skin microfluidic patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lab-on-skin microfluidic patch market size has grown exponentially in recent years. It will grow from $1.44 billion in 2025 to $1.73 billion in 2026 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to advances in microfluidics, wearable healthcare technology adoption, growth of sports analytics, increasing demand for non-invasive diagnostics, research in biofluid analysis.

The lab-on-skin microfluidic patch market size is expected to see rapid growth in the next few years. It will grow to $3.57 billion in 2030 at a compound annual growth rate (CAGR) of 19.9%. The growth in the forecast period can be attributed to integration with AI-driven analytics, expansion in personalized medicine, remote patient monitoring growth, adoption in fitness & wellness sectors, technological innovation in patch materials. Major trends in the forecast period include continuous health monitoring, non-invasive diagnostics, personalized medicine devices, sports & fitness analytics, real-time biomarker detection.

The growing focus on personalized medicine is anticipated to drive the expansion of the lab-on-skin microfluidic patch market in the coming years. Personalized medicine is a healthcare approach that tailors medical treatment and preventive strategies to an individual's genetic, biomarker, and clinical profile to achieve better therapeutic outcomes. The increasing adoption of personalized medicine is supported by advances in genomics and biotechnology, which enable accurate diagnoses and targeted therapies that enhance treatment effectiveness and reduce unnecessary interventions. Lab-on-skin microfluidic patches contribute to this approach by continuously monitoring unique biomarkers, allowing real-time, individualized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization promoting personalized medicine, the US Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients in 2023, compared to six approvals in 2022. Therefore, the rising emphasis on personalized medicine is propelling the growth of the lab-on-skin microfluidic patch market.

Companies operating in the lab-on-skin microfluidic patch market are increasingly developing advanced microfluidic technologies, such as sweat-sensing patches, to support real-time health monitoring and personalized diagnostics. A sweat-sensing patch is a wearable device that collects and analyzes sweat to track biomarkers, electrolytes, and other physiological indicators continuously. For example, in April 2024, Epicore Biosystems Inc., a US-based digital health company, launched Connected Hydration, a wearable microfluidic patch paired with a mobile application that helps industrial workers prevent dehydration and heat stress through continuous sweat and electrolyte monitoring. It offers real-time personalized hydration insights, vibration alerts, and AI-based recommendations to optimize fluid intake before fatigue or injury occurs. By integrating lab-on-skin sensing, cloud-based analytics, and a long-lasting battery system, Connected Hydration improves worker safety, productivity, and endurance in extreme heat environments across global industrial sectors.

In February 2024, Epicore Biosystems Inc. entered into a partnership with the US Anti-Doping Agency (USADA) to advance its microfluidic sweat patch technology for doping detection. This collaboration aims to enable non-invasive sweat biomarker collection for drug testing, improving the efficiency and convenience of anti-doping procedures while providing athletes with real-time health insights. The US Anti-Doping Agency is a US-based nonprofit and non-governmental organization responsible for implementing a comprehensive anti-doping program for ParaPan American sports in the United States.

Major companies operating in the lab-on-skin microfluidic patch market are Epicore Biosystems, Xsensio SA, Persperity Health Inc., Nutromics Pty Ltd., Biolinq Inc., Flow Bio Ltd., GraphWear Technologies Inc., GENTAG Inc., Nemaura Medical Inc., Kenzen Inc., Aline Inc., Eccrine Systems Inc., Nix Biosensors, Sonera, Zansors LLC, PointFit Technology Co. Ltd., Bitome Inc., Arma Biosciences, VivaLNK Inc., MC10 Inc., BioIntelliSense Inc.

North America was the largest region in the lab-on-skin microfluidic patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab-on-skin microfluidic patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lab-on-skin microfluidic patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The lab-on-skin microfluidic patch market consists of sales of sensors, microfluidic chips, flexible substrates, electrodes, biosensors, hydrogels, and wearable bands. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lab-On-Skin Microfluidic Patch Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses lab-on-skin microfluidic patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lab-on-skin microfluidic patch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lab-on-skin microfluidic patch market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Diagnostic Patches; Monitoring Patches
  • 2) By Material Type: Polymer-Based; Hybrid; Other Material Types
  • 3) By Application: Healthcare Monitoring; Disease Diagnosis; Sports And Fitness; Other Applications
  • 4) By End-User: Hospitals And Clinics; Homecare; Research Institutes; Sports And Fitness Centers; Other End-Users
  • Subsegments:
  • 1) By Diagnostic Patches: Sweat-Based Microfluidic Diagnostic Patches; Interstitial Fluid Microfluidic Diagnostic Patches; Glucose and Metabolite Detection Microfluidic Patches; Electrolyte and Biomarker Analysis Microfluidic Patches; Multi-Analyte Lab-on-Skin Diagnostic Patches
  • 2) By Monitoring Patches: Continuous Hydration Monitoring Microfluidic Patches; Continuous Lactate Monitoring Microfluidic Patches; Electrolyte Balance Monitoring Microfluidic Patches; Stress and Fatigue Monitoring Microfluidic Patches (Biochemical-Based); Personalized Health Monitoring Lab-on-Skin Patches
  • Companies Mentioned: Epicore Biosystems; Xsensio SA; Persperity Health Inc.; Nutromics Pty Ltd.; Biolinq Inc.; Flow Bio Ltd.; GraphWear Technologies Inc.; GENTAG Inc.; Nemaura Medical Inc.; Kenzen Inc.; Aline Inc.; Eccrine Systems Inc.; Nix Biosensors; Sonera; Zansors LLC; PointFit Technology Co. Ltd.; Bitome Inc.; Arma Biosciences; VivaLNK Inc.; MC10 Inc.; BioIntelliSense Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Lab-On-Skin Microfluidic Patch Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Lab-On-Skin Microfluidic Patch Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Lab-On-Skin Microfluidic Patch Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Lab-On-Skin Microfluidic Patch Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Continuous Health Monitoring
    • 4.2.2 Non-Invasive Diagnostics
    • 4.2.3 Personalized Medicine Devices
    • 4.2.4 Sports & Fitness Analytics
    • 4.2.5 Real-Time Biomarker Detection

5. Lab-On-Skin Microfluidic Patch Market Analysis Of End Use Industries

  • 5.1 Hospitals & Clinics
  • 5.2 Homecare
  • 5.3 Research Institutes
  • 5.4 Sports & Fitness Centers
  • 5.5 Elderly & Chronic Disease Patients

6. Lab-On-Skin Microfluidic Patch Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lab-On-Skin Microfluidic Patch Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Lab-On-Skin Microfluidic Patch PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Lab-On-Skin Microfluidic Patch Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Lab-On-Skin Microfluidic Patch Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Lab-On-Skin Microfluidic Patch Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lab-On-Skin Microfluidic Patch Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lab-On-Skin Microfluidic Patch Market Segmentation

  • 9.1. Global Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Patches, Monitoring Patches
  • 9.2. Global Lab-On-Skin Microfluidic Patch Market, Segmentation By Material Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymer-Based, Hybrid, Other Material Types
  • 9.3. Global Lab-On-Skin Microfluidic Patch Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Healthcare Monitoring, Disease Diagnosis, Sports And Fitness, Other Applications
  • 9.4. Global Lab-On-Skin Microfluidic Patch Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Homecare, Research Institutes, Sports And Fitness Centers, Other End-Users
  • 9.5. Global Lab-On-Skin Microfluidic Patch Market, Sub-Segmentation Of Diagnostic Patches, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sweat-Based Microfluidic Diagnostic Patches, Interstitial Fluid Microfluidic Diagnostic Patches, Glucose and Metabolite Detection Microfluidic Patches, Electrolyte and Biomarker Analysis Microfluidic Patches, Multi-Analyte Lab-on-Skin Diagnostic Patches
  • 9.6. Global Lab-On-Skin Microfluidic Patch Market, Sub-Segmentation Of Monitoring Patches, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Continuous Hydration Monitoring Microfluidic Patches, Continuous Lactate Monitoring Microfluidic Patches, Electrolyte Balance Monitoring Microfluidic Patches, Stress and Fatigue Monitoring Microfluidic Patches (Biochemical-Based), Personalized Health Monitoring Lab-on-Skin Patches

10. Lab-On-Skin Microfluidic Patch Market Regional And Country Analysis

  • 10.1. Global Lab-On-Skin Microfluidic Patch Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Lab-On-Skin Microfluidic Patch Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lab-On-Skin Microfluidic Patch Market

  • 11.1. Asia-Pacific Lab-On-Skin Microfluidic Patch Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lab-On-Skin Microfluidic Patch Market

  • 12.1. China Lab-On-Skin Microfluidic Patch Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lab-On-Skin Microfluidic Patch Market

  • 13.1. India Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lab-On-Skin Microfluidic Patch Market

  • 14.1. Japan Lab-On-Skin Microfluidic Patch Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lab-On-Skin Microfluidic Patch Market

  • 15.1. Australia Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lab-On-Skin Microfluidic Patch Market

  • 16.1. Indonesia Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lab-On-Skin Microfluidic Patch Market

  • 17.1. South Korea Lab-On-Skin Microfluidic Patch Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lab-On-Skin Microfluidic Patch Market

  • 18.1. Taiwan Lab-On-Skin Microfluidic Patch Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lab-On-Skin Microfluidic Patch Market

  • 19.1. South East Asia Lab-On-Skin Microfluidic Patch Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lab-On-Skin Microfluidic Patch Market

  • 20.1. Western Europe Lab-On-Skin Microfluidic Patch Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lab-On-Skin Microfluidic Patch Market

  • 21.1. UK Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lab-On-Skin Microfluidic Patch Market

  • 22.1. Germany Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lab-On-Skin Microfluidic Patch Market

  • 23.1. France Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lab-On-Skin Microfluidic Patch Market

  • 24.1. Italy Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lab-On-Skin Microfluidic Patch Market

  • 25.1. Spain Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lab-On-Skin Microfluidic Patch Market

  • 26.1. Eastern Europe Lab-On-Skin Microfluidic Patch Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lab-On-Skin Microfluidic Patch Market

  • 27.1. Russia Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lab-On-Skin Microfluidic Patch Market

  • 28.1. North America Lab-On-Skin Microfluidic Patch Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lab-On-Skin Microfluidic Patch Market

  • 29.1. USA Lab-On-Skin Microfluidic Patch Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lab-On-Skin Microfluidic Patch Market

  • 30.1. Canada Lab-On-Skin Microfluidic Patch Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lab-On-Skin Microfluidic Patch Market

  • 31.1. South America Lab-On-Skin Microfluidic Patch Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lab-On-Skin Microfluidic Patch Market

  • 32.1. Brazil Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lab-On-Skin Microfluidic Patch Market

  • 33.1. Middle East Lab-On-Skin Microfluidic Patch Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lab-On-Skin Microfluidic Patch Market

  • 34.1. Africa Lab-On-Skin Microfluidic Patch Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lab-On-Skin Microfluidic Patch Market Regulatory and Investment Landscape

36. Lab-On-Skin Microfluidic Patch Market Competitive Landscape And Company Profiles

  • 36.1. Lab-On-Skin Microfluidic Patch Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Lab-On-Skin Microfluidic Patch Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Lab-On-Skin Microfluidic Patch Market Company Profiles
    • 36.3.1. Epicore Biosystems Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Xsensio SA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Persperity Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Nutromics Pty Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Biolinq Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Lab-On-Skin Microfluidic Patch Market Other Major And Innovative Companies

  • Flow Bio Ltd., GraphWear Technologies Inc., GENTAG Inc., Nemaura Medical Inc., Kenzen Inc., Aline Inc., Eccrine Systems Inc., Nix Biosensors, Sonera, Zansors LLC, PointFit Technology Co. Ltd., Bitome Inc., Arma Biosciences, VivaLNK Inc., MC10 Inc.

38. Global Lab-On-Skin Microfluidic Patch Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lab-On-Skin Microfluidic Patch Market

40. Lab-On-Skin Microfluidic Patch Market High Potential Countries, Segments and Strategies

  • 40.1 Lab-On-Skin Microfluidic Patch Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Lab-On-Skin Microfluidic Patch Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Lab-On-Skin Microfluidic Patch Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer